Courtagen Life Sciences has launched NucSeekPDx, a mitochondrial disorder test that will sequence approximately 1,100 nuclear genes constituting the mitochondrial exome. The test covers 95 percent of the target bases to an average coverage of 400x. This test complements Courtagen's other mitochondrial test, MtSeekPDx, which sequences the entire mitochondrial genome.
New Products: Courtagen's NucSeekPDx
Jul 11, 2012